•
Mar 31, 2024

Sagimet Biosciences Q1 2024 Earnings Report

EPS
-$0.23
Previous year: -$2.83K
-100.0%
Gross Profit
$0
Cash and Equivalents
$194M
Previous year: $12.3M
+1470.0%
Free Cash Flow
-$6.21M
Total Assets
$195M

Sagimet Biosciences

Sagimet Biosciences